Medical Care
Global Stye Drugs Market Research Report 2025
- Jul 08, 25
- ID: 348823
- Pages: 94
- Figures: 95
- Views: 13
The global market for Stye Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Stye, also known as hordeolum, is a painful and acute infection on the upper or lower eyelid. Majority of the cases of hordeolum are due to Staphylococcus aureus followed by Staphylococcus epidermidis. All age groups can be affected, although there is a slight increase in prevalence of stye in patients aged between 30 years and 50 years. Stye can be treated with topical ointment or sometimes oral antibiotics. However, in some cases, surgeries are performed. Typically, the size of the swelling is a direct indicator of the severity of the infection. Recurrent of hordeolum is usually due to failure to eliminate the bacteria completely.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Stye Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stye Drugs.
The Stye Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Stye Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Stye Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Similasan
Bausch and Lomb
Johnson & Johnson
Novartis AG
Allergan
Daiichi Sankyo
AbbVie Inc
Sun Pharmaceutical Industries Ltd
Merck
Pfizer
XOMA
EyePoint Pharmaceuticals
Enzo Biochem Inc
TopiVert Ltd
Santen Pharmaceutical Co., Ltd
Regeneron Pharmaceuticals Inc
Segment by Type
Antibiotic
Ophthalmic Steroids
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Stye Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Stye, also known as hordeolum, is a painful and acute infection on the upper or lower eyelid. Majority of the cases of hordeolum are due to Staphylococcus aureus followed by Staphylococcus epidermidis. All age groups can be affected, although there is a slight increase in prevalence of stye in patients aged between 30 years and 50 years. Stye can be treated with topical ointment or sometimes oral antibiotics. However, in some cases, surgeries are performed. Typically, the size of the swelling is a direct indicator of the severity of the infection. Recurrent of hordeolum is usually due to failure to eliminate the bacteria completely.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Stye Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stye Drugs.
The Stye Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Stye Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Stye Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Similasan
Bausch and Lomb
Johnson & Johnson
Novartis AG
Allergan
Daiichi Sankyo
AbbVie Inc
Sun Pharmaceutical Industries Ltd
Merck
Pfizer
XOMA
EyePoint Pharmaceuticals
Enzo Biochem Inc
TopiVert Ltd
Santen Pharmaceutical Co., Ltd
Regeneron Pharmaceuticals Inc
Segment by Type
Antibiotic
Ophthalmic Steroids
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Stye Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stye Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antibiotic
1.2.3 Ophthalmic Steroids
1.3 Market by Application
1.3.1 Global Stye Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Stye Drugs Market Perspective (2020-2031)
2.2 Global Stye Drugs Growth Trends by Region
2.2.1 Global Stye Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Stye Drugs Historic Market Size by Region (2020-2025)
2.2.3 Stye Drugs Forecasted Market Size by Region (2026-2031)
2.3 Stye Drugs Market Dynamics
2.3.1 Stye Drugs Industry Trends
2.3.2 Stye Drugs Market Drivers
2.3.3 Stye Drugs Market Challenges
2.3.4 Stye Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stye Drugs Players by Revenue
3.1.1 Global Top Stye Drugs Players by Revenue (2020-2025)
3.1.2 Global Stye Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Stye Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Stye Drugs Revenue
3.4 Global Stye Drugs Market Concentration Ratio
3.4.1 Global Stye Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stye Drugs Revenue in 2024
3.5 Global Key Players of Stye Drugs Head office and Area Served
3.6 Global Key Players of Stye Drugs, Product and Application
3.7 Global Key Players of Stye Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Stye Drugs Breakdown Data by Type
4.1 Global Stye Drugs Historic Market Size by Type (2020-2025)
4.2 Global Stye Drugs Forecasted Market Size by Type (2026-2031)
5 Stye Drugs Breakdown Data by Application
5.1 Global Stye Drugs Historic Market Size by Application (2020-2025)
5.2 Global Stye Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Stye Drugs Market Size (2020-2031)
6.2 North America Stye Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Stye Drugs Market Size by Country (2020-2025)
6.4 North America Stye Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Stye Drugs Market Size (2020-2031)
7.2 Europe Stye Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Stye Drugs Market Size by Country (2020-2025)
7.4 Europe Stye Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Stye Drugs Market Size (2020-2031)
8.2 Asia-Pacific Stye Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Stye Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Stye Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Stye Drugs Market Size (2020-2031)
9.2 Latin America Stye Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Stye Drugs Market Size by Country (2020-2025)
9.4 Latin America Stye Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stye Drugs Market Size (2020-2031)
10.2 Middle East & Africa Stye Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Stye Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Stye Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Similasan
11.1.1 Similasan Company Details
11.1.2 Similasan Business Overview
11.1.3 Similasan Stye Drugs Introduction
11.1.4 Similasan Revenue in Stye Drugs Business (2020-2025)
11.1.5 Similasan Recent Development
11.2 Bausch and Lomb
11.2.1 Bausch and Lomb Company Details
11.2.2 Bausch and Lomb Business Overview
11.2.3 Bausch and Lomb Stye Drugs Introduction
11.2.4 Bausch and Lomb Revenue in Stye Drugs Business (2020-2025)
11.2.5 Bausch and Lomb Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Stye Drugs Introduction
11.3.4 Johnson & Johnson Revenue in Stye Drugs Business (2020-2025)
11.3.5 Johnson & Johnson Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Stye Drugs Introduction
11.4.4 Novartis AG Revenue in Stye Drugs Business (2020-2025)
11.4.5 Novartis AG Recent Development
11.5 Allergan
11.5.1 Allergan Company Details
11.5.2 Allergan Business Overview
11.5.3 Allergan Stye Drugs Introduction
11.5.4 Allergan Revenue in Stye Drugs Business (2020-2025)
11.5.5 Allergan Recent Development
11.6 Daiichi Sankyo
11.6.1 Daiichi Sankyo Company Details
11.6.2 Daiichi Sankyo Business Overview
11.6.3 Daiichi Sankyo Stye Drugs Introduction
11.6.4 Daiichi Sankyo Revenue in Stye Drugs Business (2020-2025)
11.6.5 Daiichi Sankyo Recent Development
11.7 AbbVie Inc
11.7.1 AbbVie Inc Company Details
11.7.2 AbbVie Inc Business Overview
11.7.3 AbbVie Inc Stye Drugs Introduction
11.7.4 AbbVie Inc Revenue in Stye Drugs Business (2020-2025)
11.7.5 AbbVie Inc Recent Development
11.8 Sun Pharmaceutical Industries Ltd
11.8.1 Sun Pharmaceutical Industries Ltd Company Details
11.8.2 Sun Pharmaceutical Industries Ltd Business Overview
11.8.3 Sun Pharmaceutical Industries Ltd Stye Drugs Introduction
11.8.4 Sun Pharmaceutical Industries Ltd Revenue in Stye Drugs Business (2020-2025)
11.8.5 Sun Pharmaceutical Industries Ltd Recent Development
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck Stye Drugs Introduction
11.9.4 Merck Revenue in Stye Drugs Business (2020-2025)
11.9.5 Merck Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Stye Drugs Introduction
11.10.4 Pfizer Revenue in Stye Drugs Business (2020-2025)
11.10.5 Pfizer Recent Development
11.11 XOMA
11.11.1 XOMA Company Details
11.11.2 XOMA Business Overview
11.11.3 XOMA Stye Drugs Introduction
11.11.4 XOMA Revenue in Stye Drugs Business (2020-2025)
11.11.5 XOMA Recent Development
11.12 EyePoint Pharmaceuticals
11.12.1 EyePoint Pharmaceuticals Company Details
11.12.2 EyePoint Pharmaceuticals Business Overview
11.12.3 EyePoint Pharmaceuticals Stye Drugs Introduction
11.12.4 EyePoint Pharmaceuticals Revenue in Stye Drugs Business (2020-2025)
11.12.5 EyePoint Pharmaceuticals Recent Development
11.13 Enzo Biochem Inc
11.13.1 Enzo Biochem Inc Company Details
11.13.2 Enzo Biochem Inc Business Overview
11.13.3 Enzo Biochem Inc Stye Drugs Introduction
11.13.4 Enzo Biochem Inc Revenue in Stye Drugs Business (2020-2025)
11.13.5 Enzo Biochem Inc Recent Development
11.14 TopiVert Ltd
11.14.1 TopiVert Ltd Company Details
11.14.2 TopiVert Ltd Business Overview
11.14.3 TopiVert Ltd Stye Drugs Introduction
11.14.4 TopiVert Ltd Revenue in Stye Drugs Business (2020-2025)
11.14.5 TopiVert Ltd Recent Development
11.15 Santen Pharmaceutical Co., Ltd
11.15.1 Santen Pharmaceutical Co., Ltd Company Details
11.15.2 Santen Pharmaceutical Co., Ltd Business Overview
11.15.3 Santen Pharmaceutical Co., Ltd Stye Drugs Introduction
11.15.4 Santen Pharmaceutical Co., Ltd Revenue in Stye Drugs Business (2020-2025)
11.15.5 Santen Pharmaceutical Co., Ltd Recent Development
11.16 Regeneron Pharmaceuticals Inc
11.16.1 Regeneron Pharmaceuticals Inc Company Details
11.16.2 Regeneron Pharmaceuticals Inc Business Overview
11.16.3 Regeneron Pharmaceuticals Inc Stye Drugs Introduction
11.16.4 Regeneron Pharmaceuticals Inc Revenue in Stye Drugs Business (2020-2025)
11.16.5 Regeneron Pharmaceuticals Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stye Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antibiotic
1.2.3 Ophthalmic Steroids
1.3 Market by Application
1.3.1 Global Stye Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Stye Drugs Market Perspective (2020-2031)
2.2 Global Stye Drugs Growth Trends by Region
2.2.1 Global Stye Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Stye Drugs Historic Market Size by Region (2020-2025)
2.2.3 Stye Drugs Forecasted Market Size by Region (2026-2031)
2.3 Stye Drugs Market Dynamics
2.3.1 Stye Drugs Industry Trends
2.3.2 Stye Drugs Market Drivers
2.3.3 Stye Drugs Market Challenges
2.3.4 Stye Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stye Drugs Players by Revenue
3.1.1 Global Top Stye Drugs Players by Revenue (2020-2025)
3.1.2 Global Stye Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Stye Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Stye Drugs Revenue
3.4 Global Stye Drugs Market Concentration Ratio
3.4.1 Global Stye Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stye Drugs Revenue in 2024
3.5 Global Key Players of Stye Drugs Head office and Area Served
3.6 Global Key Players of Stye Drugs, Product and Application
3.7 Global Key Players of Stye Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Stye Drugs Breakdown Data by Type
4.1 Global Stye Drugs Historic Market Size by Type (2020-2025)
4.2 Global Stye Drugs Forecasted Market Size by Type (2026-2031)
5 Stye Drugs Breakdown Data by Application
5.1 Global Stye Drugs Historic Market Size by Application (2020-2025)
5.2 Global Stye Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Stye Drugs Market Size (2020-2031)
6.2 North America Stye Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Stye Drugs Market Size by Country (2020-2025)
6.4 North America Stye Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Stye Drugs Market Size (2020-2031)
7.2 Europe Stye Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Stye Drugs Market Size by Country (2020-2025)
7.4 Europe Stye Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Stye Drugs Market Size (2020-2031)
8.2 Asia-Pacific Stye Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Stye Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Stye Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Stye Drugs Market Size (2020-2031)
9.2 Latin America Stye Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Stye Drugs Market Size by Country (2020-2025)
9.4 Latin America Stye Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stye Drugs Market Size (2020-2031)
10.2 Middle East & Africa Stye Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Stye Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Stye Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Similasan
11.1.1 Similasan Company Details
11.1.2 Similasan Business Overview
11.1.3 Similasan Stye Drugs Introduction
11.1.4 Similasan Revenue in Stye Drugs Business (2020-2025)
11.1.5 Similasan Recent Development
11.2 Bausch and Lomb
11.2.1 Bausch and Lomb Company Details
11.2.2 Bausch and Lomb Business Overview
11.2.3 Bausch and Lomb Stye Drugs Introduction
11.2.4 Bausch and Lomb Revenue in Stye Drugs Business (2020-2025)
11.2.5 Bausch and Lomb Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Stye Drugs Introduction
11.3.4 Johnson & Johnson Revenue in Stye Drugs Business (2020-2025)
11.3.5 Johnson & Johnson Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Stye Drugs Introduction
11.4.4 Novartis AG Revenue in Stye Drugs Business (2020-2025)
11.4.5 Novartis AG Recent Development
11.5 Allergan
11.5.1 Allergan Company Details
11.5.2 Allergan Business Overview
11.5.3 Allergan Stye Drugs Introduction
11.5.4 Allergan Revenue in Stye Drugs Business (2020-2025)
11.5.5 Allergan Recent Development
11.6 Daiichi Sankyo
11.6.1 Daiichi Sankyo Company Details
11.6.2 Daiichi Sankyo Business Overview
11.6.3 Daiichi Sankyo Stye Drugs Introduction
11.6.4 Daiichi Sankyo Revenue in Stye Drugs Business (2020-2025)
11.6.5 Daiichi Sankyo Recent Development
11.7 AbbVie Inc
11.7.1 AbbVie Inc Company Details
11.7.2 AbbVie Inc Business Overview
11.7.3 AbbVie Inc Stye Drugs Introduction
11.7.4 AbbVie Inc Revenue in Stye Drugs Business (2020-2025)
11.7.5 AbbVie Inc Recent Development
11.8 Sun Pharmaceutical Industries Ltd
11.8.1 Sun Pharmaceutical Industries Ltd Company Details
11.8.2 Sun Pharmaceutical Industries Ltd Business Overview
11.8.3 Sun Pharmaceutical Industries Ltd Stye Drugs Introduction
11.8.4 Sun Pharmaceutical Industries Ltd Revenue in Stye Drugs Business (2020-2025)
11.8.5 Sun Pharmaceutical Industries Ltd Recent Development
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck Stye Drugs Introduction
11.9.4 Merck Revenue in Stye Drugs Business (2020-2025)
11.9.5 Merck Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Stye Drugs Introduction
11.10.4 Pfizer Revenue in Stye Drugs Business (2020-2025)
11.10.5 Pfizer Recent Development
11.11 XOMA
11.11.1 XOMA Company Details
11.11.2 XOMA Business Overview
11.11.3 XOMA Stye Drugs Introduction
11.11.4 XOMA Revenue in Stye Drugs Business (2020-2025)
11.11.5 XOMA Recent Development
11.12 EyePoint Pharmaceuticals
11.12.1 EyePoint Pharmaceuticals Company Details
11.12.2 EyePoint Pharmaceuticals Business Overview
11.12.3 EyePoint Pharmaceuticals Stye Drugs Introduction
11.12.4 EyePoint Pharmaceuticals Revenue in Stye Drugs Business (2020-2025)
11.12.5 EyePoint Pharmaceuticals Recent Development
11.13 Enzo Biochem Inc
11.13.1 Enzo Biochem Inc Company Details
11.13.2 Enzo Biochem Inc Business Overview
11.13.3 Enzo Biochem Inc Stye Drugs Introduction
11.13.4 Enzo Biochem Inc Revenue in Stye Drugs Business (2020-2025)
11.13.5 Enzo Biochem Inc Recent Development
11.14 TopiVert Ltd
11.14.1 TopiVert Ltd Company Details
11.14.2 TopiVert Ltd Business Overview
11.14.3 TopiVert Ltd Stye Drugs Introduction
11.14.4 TopiVert Ltd Revenue in Stye Drugs Business (2020-2025)
11.14.5 TopiVert Ltd Recent Development
11.15 Santen Pharmaceutical Co., Ltd
11.15.1 Santen Pharmaceutical Co., Ltd Company Details
11.15.2 Santen Pharmaceutical Co., Ltd Business Overview
11.15.3 Santen Pharmaceutical Co., Ltd Stye Drugs Introduction
11.15.4 Santen Pharmaceutical Co., Ltd Revenue in Stye Drugs Business (2020-2025)
11.15.5 Santen Pharmaceutical Co., Ltd Recent Development
11.16 Regeneron Pharmaceuticals Inc
11.16.1 Regeneron Pharmaceuticals Inc Company Details
11.16.2 Regeneron Pharmaceuticals Inc Business Overview
11.16.3 Regeneron Pharmaceuticals Inc Stye Drugs Introduction
11.16.4 Regeneron Pharmaceuticals Inc Revenue in Stye Drugs Business (2020-2025)
11.16.5 Regeneron Pharmaceuticals Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Stye Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Antibiotic
Table 3. Key Players of Ophthalmic Steroids
Table 4. Global Stye Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Stye Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Stye Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Stye Drugs Market Share by Region (2020-2025)
Table 8. Global Stye Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Stye Drugs Market Share by Region (2026-2031)
Table 10. Stye Drugs Market Trends
Table 11. Stye Drugs Market Drivers
Table 12. Stye Drugs Market Challenges
Table 13. Stye Drugs Market Restraints
Table 14. Global Stye Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Stye Drugs Market Share by Players (2020-2025)
Table 16. Global Top Stye Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stye Drugs as of 2024)
Table 17. Ranking of Global Top Stye Drugs Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Stye Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Stye Drugs, Headquarters and Area Served
Table 20. Global Key Players of Stye Drugs, Product and Application
Table 21. Global Key Players of Stye Drugs, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Stye Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Stye Drugs Revenue Market Share by Type (2020-2025)
Table 25. Global Stye Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Stye Drugs Revenue Market Share by Type (2026-2031)
Table 27. Global Stye Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Stye Drugs Revenue Market Share by Application (2020-2025)
Table 29. Global Stye Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Stye Drugs Revenue Market Share by Application (2026-2031)
Table 31. North America Stye Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Stye Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Stye Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Stye Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Stye Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Stye Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Stye Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Stye Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Stye Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Stye Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Stye Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Stye Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Stye Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Stye Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Stye Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 46. Similasan Company Details
Table 47. Similasan Business Overview
Table 48. Similasan Stye Drugs Product
Table 49. Similasan Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 50. Similasan Recent Development
Table 51. Bausch and Lomb Company Details
Table 52. Bausch and Lomb Business Overview
Table 53. Bausch and Lomb Stye Drugs Product
Table 54. Bausch and Lomb Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 55. Bausch and Lomb Recent Development
Table 56. Johnson & Johnson Company Details
Table 57. Johnson & Johnson Business Overview
Table 58. Johnson & Johnson Stye Drugs Product
Table 59. Johnson & Johnson Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 60. Johnson & Johnson Recent Development
Table 61. Novartis AG Company Details
Table 62. Novartis AG Business Overview
Table 63. Novartis AG Stye Drugs Product
Table 64. Novartis AG Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 65. Novartis AG Recent Development
Table 66. Allergan Company Details
Table 67. Allergan Business Overview
Table 68. Allergan Stye Drugs Product
Table 69. Allergan Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 70. Allergan Recent Development
Table 71. Daiichi Sankyo Company Details
Table 72. Daiichi Sankyo Business Overview
Table 73. Daiichi Sankyo Stye Drugs Product
Table 74. Daiichi Sankyo Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 75. Daiichi Sankyo Recent Development
Table 76. AbbVie Inc Company Details
Table 77. AbbVie Inc Business Overview
Table 78. AbbVie Inc Stye Drugs Product
Table 79. AbbVie Inc Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 80. AbbVie Inc Recent Development
Table 81. Sun Pharmaceutical Industries Ltd Company Details
Table 82. Sun Pharmaceutical Industries Ltd Business Overview
Table 83. Sun Pharmaceutical Industries Ltd Stye Drugs Product
Table 84. Sun Pharmaceutical Industries Ltd Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 85. Sun Pharmaceutical Industries Ltd Recent Development
Table 86. Merck Company Details
Table 87. Merck Business Overview
Table 88. Merck Stye Drugs Product
Table 89. Merck Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 90. Merck Recent Development
Table 91. Pfizer Company Details
Table 92. Pfizer Business Overview
Table 93. Pfizer Stye Drugs Product
Table 94. Pfizer Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 95. Pfizer Recent Development
Table 96. XOMA Company Details
Table 97. XOMA Business Overview
Table 98. XOMA Stye Drugs Product
Table 99. XOMA Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 100. XOMA Recent Development
Table 101. EyePoint Pharmaceuticals Company Details
Table 102. EyePoint Pharmaceuticals Business Overview
Table 103. EyePoint Pharmaceuticals Stye Drugs Product
Table 104. EyePoint Pharmaceuticals Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 105. EyePoint Pharmaceuticals Recent Development
Table 106. Enzo Biochem Inc Company Details
Table 107. Enzo Biochem Inc Business Overview
Table 108. Enzo Biochem Inc Stye Drugs Product
Table 109. Enzo Biochem Inc Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 110. Enzo Biochem Inc Recent Development
Table 111. TopiVert Ltd Company Details
Table 112. TopiVert Ltd Business Overview
Table 113. TopiVert Ltd Stye Drugs Product
Table 114. TopiVert Ltd Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 115. TopiVert Ltd Recent Development
Table 116. Santen Pharmaceutical Co., Ltd Company Details
Table 117. Santen Pharmaceutical Co., Ltd Business Overview
Table 118. Santen Pharmaceutical Co., Ltd Stye Drugs Product
Table 119. Santen Pharmaceutical Co., Ltd Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 120. Santen Pharmaceutical Co., Ltd Recent Development
Table 121. Regeneron Pharmaceuticals Inc Company Details
Table 122. Regeneron Pharmaceuticals Inc Business Overview
Table 123. Regeneron Pharmaceuticals Inc Stye Drugs Product
Table 124. Regeneron Pharmaceuticals Inc Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 125. Regeneron Pharmaceuticals Inc Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. Stye Drugs Picture
Figure 2. Global Stye Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Stye Drugs Market Share by Type: 2024 VS 2031
Figure 4. Antibiotic Features
Figure 5. Ophthalmic Steroids Features
Figure 6. Global Stye Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Stye Drugs Market Share by Application: 2024 VS 2031
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Stye Drugs Report Years Considered
Figure 12. Global Stye Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Stye Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Stye Drugs Market Share by Region: 2024 VS 2031
Figure 15. Global Stye Drugs Market Share by Players in 2024
Figure 16. Global Top Stye Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stye Drugs as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Stye Drugs Revenue in 2024
Figure 18. North America Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Stye Drugs Market Share by Country (2020-2031)
Figure 20. United States Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Stye Drugs Market Share by Country (2020-2031)
Figure 24. Germany Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Stye Drugs Market Share by Region (2020-2031)
Figure 32. China Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Stye Drugs Market Share by Country (2020-2031)
Figure 40. Mexico Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Stye Drugs Market Share by Country (2020-2031)
Figure 44. Turkey Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Similasan Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 48. Bausch and Lomb Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 49. Johnson & Johnson Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 50. Novartis AG Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 51. Allergan Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 52. Daiichi Sankyo Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 53. AbbVie Inc Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 54. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 55. Merck Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 56. Pfizer Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 57. XOMA Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 58. EyePoint Pharmaceuticals Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 59. Enzo Biochem Inc Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 60. TopiVert Ltd Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 61. Santen Pharmaceutical Co., Ltd Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 62. Regeneron Pharmaceuticals Inc Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Stye Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Antibiotic
Table 3. Key Players of Ophthalmic Steroids
Table 4. Global Stye Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Stye Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Stye Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Stye Drugs Market Share by Region (2020-2025)
Table 8. Global Stye Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Stye Drugs Market Share by Region (2026-2031)
Table 10. Stye Drugs Market Trends
Table 11. Stye Drugs Market Drivers
Table 12. Stye Drugs Market Challenges
Table 13. Stye Drugs Market Restraints
Table 14. Global Stye Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Stye Drugs Market Share by Players (2020-2025)
Table 16. Global Top Stye Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stye Drugs as of 2024)
Table 17. Ranking of Global Top Stye Drugs Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Stye Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Stye Drugs, Headquarters and Area Served
Table 20. Global Key Players of Stye Drugs, Product and Application
Table 21. Global Key Players of Stye Drugs, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Stye Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Stye Drugs Revenue Market Share by Type (2020-2025)
Table 25. Global Stye Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Stye Drugs Revenue Market Share by Type (2026-2031)
Table 27. Global Stye Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Stye Drugs Revenue Market Share by Application (2020-2025)
Table 29. Global Stye Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Stye Drugs Revenue Market Share by Application (2026-2031)
Table 31. North America Stye Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Stye Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Stye Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Stye Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Stye Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Stye Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Stye Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Stye Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Stye Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Stye Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Stye Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Stye Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Stye Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Stye Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Stye Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 46. Similasan Company Details
Table 47. Similasan Business Overview
Table 48. Similasan Stye Drugs Product
Table 49. Similasan Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 50. Similasan Recent Development
Table 51. Bausch and Lomb Company Details
Table 52. Bausch and Lomb Business Overview
Table 53. Bausch and Lomb Stye Drugs Product
Table 54. Bausch and Lomb Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 55. Bausch and Lomb Recent Development
Table 56. Johnson & Johnson Company Details
Table 57. Johnson & Johnson Business Overview
Table 58. Johnson & Johnson Stye Drugs Product
Table 59. Johnson & Johnson Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 60. Johnson & Johnson Recent Development
Table 61. Novartis AG Company Details
Table 62. Novartis AG Business Overview
Table 63. Novartis AG Stye Drugs Product
Table 64. Novartis AG Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 65. Novartis AG Recent Development
Table 66. Allergan Company Details
Table 67. Allergan Business Overview
Table 68. Allergan Stye Drugs Product
Table 69. Allergan Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 70. Allergan Recent Development
Table 71. Daiichi Sankyo Company Details
Table 72. Daiichi Sankyo Business Overview
Table 73. Daiichi Sankyo Stye Drugs Product
Table 74. Daiichi Sankyo Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 75. Daiichi Sankyo Recent Development
Table 76. AbbVie Inc Company Details
Table 77. AbbVie Inc Business Overview
Table 78. AbbVie Inc Stye Drugs Product
Table 79. AbbVie Inc Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 80. AbbVie Inc Recent Development
Table 81. Sun Pharmaceutical Industries Ltd Company Details
Table 82. Sun Pharmaceutical Industries Ltd Business Overview
Table 83. Sun Pharmaceutical Industries Ltd Stye Drugs Product
Table 84. Sun Pharmaceutical Industries Ltd Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 85. Sun Pharmaceutical Industries Ltd Recent Development
Table 86. Merck Company Details
Table 87. Merck Business Overview
Table 88. Merck Stye Drugs Product
Table 89. Merck Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 90. Merck Recent Development
Table 91. Pfizer Company Details
Table 92. Pfizer Business Overview
Table 93. Pfizer Stye Drugs Product
Table 94. Pfizer Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 95. Pfizer Recent Development
Table 96. XOMA Company Details
Table 97. XOMA Business Overview
Table 98. XOMA Stye Drugs Product
Table 99. XOMA Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 100. XOMA Recent Development
Table 101. EyePoint Pharmaceuticals Company Details
Table 102. EyePoint Pharmaceuticals Business Overview
Table 103. EyePoint Pharmaceuticals Stye Drugs Product
Table 104. EyePoint Pharmaceuticals Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 105. EyePoint Pharmaceuticals Recent Development
Table 106. Enzo Biochem Inc Company Details
Table 107. Enzo Biochem Inc Business Overview
Table 108. Enzo Biochem Inc Stye Drugs Product
Table 109. Enzo Biochem Inc Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 110. Enzo Biochem Inc Recent Development
Table 111. TopiVert Ltd Company Details
Table 112. TopiVert Ltd Business Overview
Table 113. TopiVert Ltd Stye Drugs Product
Table 114. TopiVert Ltd Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 115. TopiVert Ltd Recent Development
Table 116. Santen Pharmaceutical Co., Ltd Company Details
Table 117. Santen Pharmaceutical Co., Ltd Business Overview
Table 118. Santen Pharmaceutical Co., Ltd Stye Drugs Product
Table 119. Santen Pharmaceutical Co., Ltd Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 120. Santen Pharmaceutical Co., Ltd Recent Development
Table 121. Regeneron Pharmaceuticals Inc Company Details
Table 122. Regeneron Pharmaceuticals Inc Business Overview
Table 123. Regeneron Pharmaceuticals Inc Stye Drugs Product
Table 124. Regeneron Pharmaceuticals Inc Revenue in Stye Drugs Business (2020-2025) & (US$ Million)
Table 125. Regeneron Pharmaceuticals Inc Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. Stye Drugs Picture
Figure 2. Global Stye Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Stye Drugs Market Share by Type: 2024 VS 2031
Figure 4. Antibiotic Features
Figure 5. Ophthalmic Steroids Features
Figure 6. Global Stye Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Stye Drugs Market Share by Application: 2024 VS 2031
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Stye Drugs Report Years Considered
Figure 12. Global Stye Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Stye Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Stye Drugs Market Share by Region: 2024 VS 2031
Figure 15. Global Stye Drugs Market Share by Players in 2024
Figure 16. Global Top Stye Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stye Drugs as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Stye Drugs Revenue in 2024
Figure 18. North America Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Stye Drugs Market Share by Country (2020-2031)
Figure 20. United States Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Stye Drugs Market Share by Country (2020-2031)
Figure 24. Germany Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Stye Drugs Market Share by Region (2020-2031)
Figure 32. China Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Stye Drugs Market Share by Country (2020-2031)
Figure 40. Mexico Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Stye Drugs Market Share by Country (2020-2031)
Figure 44. Turkey Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Stye Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Similasan Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 48. Bausch and Lomb Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 49. Johnson & Johnson Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 50. Novartis AG Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 51. Allergan Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 52. Daiichi Sankyo Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 53. AbbVie Inc Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 54. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 55. Merck Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 56. Pfizer Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 57. XOMA Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 58. EyePoint Pharmaceuticals Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 59. Enzo Biochem Inc Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 60. TopiVert Ltd Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 61. Santen Pharmaceutical Co., Ltd Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 62. Regeneron Pharmaceuticals Inc Revenue Growth Rate in Stye Drugs Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232